Creo Dlx
Payments companies reported to CMS as associated with Creo Dlx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Creo Dlx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Creo Dlx
These are the largest totals companies reported as associated with Creo Dlx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kevin Cahill | Supply, NC | Neurological Surgery | $27,720.87 |
| Richard Lee | Newport Beach, CA | Plastic Surgery | $9,240.30 |
| Ilya Laufer | New York, NY | Neurological Surgery | $9,021.84 |
| Zachariah George | New York, NY | Neurological Surgery | $162.63 |
| Randall Graham | Dallas, TX | Neurological Surgery | $138.44 |
| Elizabeth Lord | Santa Monica, CA | Orthopaedic Surgery of The Spine | $118.95 |
| Cyrus Wong | Fort Worth, TX | Neurological Surgery | $56.70 |
| Hao-Hua Wu | Orange, CA | Orthopaedic Surgery of The Spine | $43.82 |
| Emily Mills | Orange, CA | Orthopaedic Surgery of The Spine | $43.82 |
| William Tally | Athens, GA | Orthopaedic Surgery | $41.70 |
Prescribed Creo Dlx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.